OneChain Immunotherapeutics’ Post

💊 𝗗𝗿𝘂𝗴 + 𝗗𝗶𝗴𝗶𝘁𝗮𝗹 𝗮𝘀 𝘁𝗵𝗲 𝗙𝘂𝘁𝘂𝗿𝗲 𝗦𝘁𝗮𝗻𝗱𝗮𝗿𝗱 𝗼𝗳 𝗖𝗮𝗿𝗲? 𝗖𝗼𝗻𝘀𝗶𝗱𝗲𝗿𝗮𝘁𝗶𝗼𝗻𝘀 𝗳𝗼𝗿 𝗔𝗰𝗵𝗶𝗲𝘃𝗶𝗻𝗴 𝗦𝘂𝗰𝗰𝗲𝘀𝘀 𝘄𝗶𝘁𝗵 𝗗𝗧𝘅 𝗗𝗿𝘂𝗴 𝗖𝗼𝗺𝗽𝗮𝗻𝗶𝗼𝗻 𝗦𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝘀 Join us at the 𝟰𝘁𝗵 𝗗𝗶𝗴𝗶𝘁𝗮𝗹 𝗛𝗲𝗮𝗹𝘁𝗵 𝗖𝗼𝗻𝗳𝗲𝗿𝗲𝗻𝗰𝗲 on November 7-8 in 𝗟𝗶𝘀𝗯𝗼𝗻 and learn from Pete Brockmeier, Global Associate Director, Digital Health, Novo Nordisk. Across many industries, modern products include a digital component, enabling personalization, enhanced experiences, and generating valuable data for customers and companies. In medicine, “drug + digital" offerings can similarly improve patient experiences and outcomes, leveraging clinically validated DTx companion apps to simplify and optimize medication use. However, the adoption of these solutions has been challenged by regulatory and distribution complexities and unclear or lacking incentives for key stakeholders in the value chain. Pete's talk will explore practical strategies to overcome these hurdles and effectively deliver DTx drug companion apps to patients, unlocking their potential benefits. At the 4th Digital Health Conference in Lisbon, you will also learn from speakers: 🎤 Ghaith Sankari, Head of Global Digital Health Data Science, Bayer 🎤 Paula Salme Sandrak, Product Strategist (dHealth & Health AI), Bayer 🎤 Dr. Jochen Hurlebaus, Head Digital Health Innovation, Roche Information Solutions 🎤 Dr. Ricardo Sáinz Fuertes, Global Director Digital Health Solutions NEURii Program Director, Eisai EMEA 🎤 Sridevi Nagarajan, Head Digital Regulatory Strategy, AstraZeneca 🎤 Lu Zheng, Head of Value-Based Partnerships and Digital Health, Europe & Canada, Takeda 🎤 Dan Ma, Head of Innovation & New Commercial Partnerships, Sandoz 🎤 Ayaka Yanagisawa, Former Head of Data Analytics, Biogen 🎤 Gemma Malla Salomó, Head of Digital Medicines Iberia & Business Unit Head Ophthalmology, Angelini Pharma 🎤 Leslie Anne Fendt, Integrated Solutions Program Lead, Remote Vision Monitoring (myVisionTrack / mVT(x) / Home Vision Monitor), Roche 🎤 Pete Brockmeier, Global Associate Director, Digital Health, Novo Nordisk 🎤 Miguel Amador, Partner and Chief Innovation Officer, Complear 🎤 Charlotte S., Senior Digital Health Scientist, Lundbeck 🎤Julia Chernova, Associate Director, Clinical Statistics and Digital Health, Bayer and others... Gain insights from industry leaders and explore how to navigate the evolving landscape of digital health to achieve meaningful impact and sustainable advancements in patient care. 📍 𝗔𝗹𝘁𝗶𝘀 𝗚𝗿𝗮𝗻𝗱 𝗛𝗼𝘁𝗲𝗹, 𝗟𝗶𝘀𝗯𝗼𝗻 📆 7-8 November 2024 💺 Limited to 100 seats for optimal networking ➡ Register here https://lnkd.in/d8GG8RkM ⏰  𝟰𝟴 𝗵𝗼𝘂𝗿𝘀 𝗳𝗼𝗿 𝗘𝗮𝗿𝗹𝘆 𝗕𝗶𝗿𝗱 𝗧𝗶𝗰𝗸𝗲𝘁𝘀, 𝗱𝗼𝗻'𝘁 𝗺𝗶𝘀𝘀 𝘁𝗵𝗶𝘀 𝗼𝗽𝗽𝗼𝗿𝘁𝘂𝗻𝗶𝘁𝘆!⏰ #DigitalHealth #Dtx #𝗗𝗛𝗨𝗕𝗜𝗤 Be part of the revolution in healthcare! See you in Lisbon!

🔬 Exploring Revenue Generation Opportunities in Pathology Labs 🔬 As the Founder of VitalCare Response Centre and a passionate advocate for holistic health, I am constantly seeking avenues to enhance our services and make a positive impact in the healthcare industry. Today, I want to shed light on the significant revenue generation opportunities within pathology labs. Pathology labs play a crucial role in healthcare by providing essential diagnostic insights that inform treatment decisions. However, they are not just about diagnoses; they also present lucrative opportunities for revenue generation. Here's how: 1. **Diversification of Services**: Beyond routine tests, pathology labs can diversify their services to include specialized tests catering to niche markets such as genetic testing, personalized medicine, and wellness screenings. By tapping into emerging trends and technologies, labs can attract new clients and increase revenue streams. 2. **Partnerships and Collaborations**: Collaborating with healthcare providers, pharmaceutical companies, and research institutions can open doors to new revenue streams. Partnerships can range from conducting clinical trials to offering diagnostic services for drug development, thereby fostering innovation while generating revenue. 3. **Efficiency and Automation**: Investing in automation and digitalization can streamline lab processes, reduce turnaround times, and improve overall efficiency. By optimizing workflows and minimizing errors, labs can increase productivity and capacity utilization, ultimately boosting revenue. 4. **Value-added Services**: Offering value-added services such as telemedicine consultations, health screenings, and wellness programs can attract a broader client base and enhance the overall patient experience. These additional services not only generate revenue but also foster long-term patient engagement and loyalty. 5. **Market Expansion**: Exploring new markets and geographic regions can present untapped revenue opportunities for pathology labs. Whether through physical expansion or leveraging telemedicine solutions, labs can reach underserved communities and expand their customer base. At VitalCare Response Centre, we are committed to embracing innovation and seizing opportunities for growth in the pathology lab space. By staying at the forefront of advancements and continuously evolving our services, we aim to drive positive outcomes for both our patients and our business. Let's continue to collaborate, innovate, and harness the potential of pathology labs to shape the future of healthcare together! #HealthcareInnovation #PathologyLabs #RevenueGeneration #HealthTech #HolisticHealth #VitalCareResponseCentre

I strongly recommend this programme to those of you with innovative projects in the areas of health and biomedicine.

The integration of AI holds the promise of catalyzing innovation and spearheading a healthcare reinvention. MedTech companies that can successfully integrate these technologies into their operations are poised not only to thrive but also to lead the transformation of healthcare delivery. Read more: https://lnkd.in/gmQrpT8Y #financialtimes #investing #financeandeconomy #capitalraising #businessandmanagement #capital #startupstrategies #biopharma #biopharmaceuticals #pharma #technology #biopharmaceuticals #biopharma #investment #innovation #innovationinhealthcare #mna #mergersandacquisitions #biology #startup #diagnostics #diagnostictesting #medicaldevices #medicaldevice #digitisation #digitaltransformation #digitalhealth #digitalcare #medicaldeviceinnovation #medical #healthtech #wereabletechnology #futureofhealthcare #digitalhealth #breatcancerawareness #imagingtechnologies #imaging #medtech #artificialintelligence #ai #digitaltherapeutics #digitalhealth #healthtech #sustainabilityinhealthcare #healthcareinnovation #Switzerland #funding #investmentopportunities #investmentstrategy #investmentresearch #biotechinvesting #medtechinvesting #healthtech #medtechnews MedCity News MedTech Innovator MedTech Dive MedTech Minis MedTech & Life Science Panel - For Healthcare Experts MedTechNews MedTechNews

Recently, I had the pleasure of engaging in lengthy discussions with founders and executives of thirty Canadian image-guided therapy companies taking part in INOVAIT Canada’s Market Research Initiative. With this initiative we were seeking to capture a snapshot of a thriving sector made up of companies developing and marketing advanced and innovative healthcare technologies improving the lives of patients and driving economic growth. We wanted to better understand the stories, challenges, and needs of these companies so we could better understand how they might be supported, so we engaged them in qualitative interviews and collected some hard data to do just that. We tend to naturally end up talking about challenges because, especially in a startup environment, one is always anticipating and overcoming what may seem like a neverending succession of barriers. We certainly heard about challenges, of course, but that wasn't all we heard. The companies in the INOVAIT Canada Network are a community of like-minded individuals actively engaging in knowledge-sharing and mutual support, who are adhering to the mantra of elevating one means elevating all. We heard pride and enthusiasm about how being embedded in the Canadian ecosystem has provided important strategic advantages, including partnerships with world-class academic and clinical research institutions, access to high calibre talent, numerous support programs, and ample sources of non-dilutive funding. They asked us to spread the word about what Canada and this sector have to offer. So take it from the founders and executives of thirty companies (in the form of facts, figures, and quotes we've distributed throughout the report): Canada is a prime location for building image-guided therapy companies. If you're engaged in or interested in image-guided therapy technologies, medical devices, or even Canadian medtech more generally, I would encourage you to head over to inovait.ca/reports/ and grab yourself a copy. We at INOVAIT Canada have been carrying the message of the strength and investment opportunity of the Canadian image-guided therapy sector with us wherever we go for quite some time. Now we'll also be carrying this report!

Green Genome and Primary Healthtech Join Forces for the Launch of Mobilab V1 Revolutionizing Diagnostics Across India In a groundbreaking partnership, Green Genome has successfully collaborated with Primary Healthtech to launch the Mobilab V1—a multi-parameter, pocket-sized point-of-care testing (POCT) device that is set to transform diagnostics across India. This innovative device is designed to make diagnostics more affordable, accessible, and digitally connected, even in the most remote locations. The Mobilab V1 offers an impressive capacity, capable of performing up to 150 tests on a single charge. With its app-enabled, digitally connected ecosystem, the device is robust and reliable for users in all environments. The Mobilab V1 enables the testing of more than 25 key parameters related to critical organs such as the kidney, heart, liver, and pancreas, making it a versatile tool for healthcare providers. The collaboration between Green Genome and Primary Healthtech marks a significant step in making cutting-edge diagnostics available at a much lower cost. This co-branded effort has led to the establishment of production lines for the Mobilab V1 in various units across India, reflecting the commitment of both companies to scaling innovation in healthcare. Green Genome is proud to play a pivotal role in the production and marketing of the Mobilab V1, ensuring that more people have access to essential diagnostic tools without the burden of high costs. This compact, user-friendly device is set to be a game-changer for healthcare professionals and patients alike, bringing modern diagnostics to the masses in a pocket-friendly package. Through this partnership, Green Genome and Primary Healthtech are not only advancing healthcare technology but also improving the reach of diagnostics, ensuring that every corner of India has access to vital health information. Simardeep Chhabra Ajit Biwalkar Sahil Jagnani Mobilab (by Primary Healthtech) Hindustan Latex Family Planning Promotion Trust (HLFPPT) HLL Biotech Limited HLL LIFECARE LIMITED Hites Mobile Innovation Network Mobile Medical AMBULANCE ACCESS FOUNDATION INDIA SBI Foundation Akanksha Singh

👉 Curious about the latest #DigitalHealth startups joining R2GConnect.com and how they’re addressing global healthcare challenges? Check out the newest companies from Italy, Germany, Sweden, the United Kingdom, and Mexico: ✔️ Lumina Salud - Personalized, effective and sustainable weight loss programs supported by responsibly prescribed weight loss medication. 💊 Endocrinology HQ: Sweden ✔️ PicturaBio - The 1-minute pathogen detection platform. 💊 Infectious diseases HQ: United Kingdom ✔️ LAIA Technologies - A digital platform for managing clinical data, enhancing early cancer detection with AI. 💊 Women’s Health, Oncology, Gynecology HQ: Mexico ✔️ Edamam - Accurate, real-time nutrition data services for businesses in the food, health, and wellness sectors. 💊 Cardiology, Cardiovascular, Dentistry, Dermatology, Endocrinology, Gastroenterology, Gynecology, Hematology, Other HQ: United States ✔️ Artiness - On a mission to be the new standard of care in Europe for the procedural support of mini-invasive surgeries, through holographic innovative solutions for medical imaging. 💊 Cardiovascular, Cardiology HQ: Italy ✔️ UMAXLIFE - Reinventing the way to diagnose, manage and care for mental health by tracking how the body reacts to experiences. 💊 Cardiology, Cardiovascular, Dentistry, Dermatology, Endocrinology, Gastroenterology, Gynecology, Hematology, Other HQ: UMAXLIFE ✔️ One Health Vision S.R.L. - An innovative digital health company specializing in DTx, certified as Class I CE medical devices. 💊 Multiple sclerosis, Mental Health, Neurology, Wellness HQ: Italy ✔️ Stardots, Inc - Makes big data easy! Mathematical approach to develop biomarkers, analyze disease progression & deliver treatment optimization in nervous system disorders. 💊 Neurology, Mental Health HQ: Sweden ✔️ Trajectory - Uses gamification to transform the $49B workplace well-being industry by providing a solution to loneliness, the greatest impediment to human flourishing. (Bobby Holley) 💊 Mental Health, Wellness HQ: United States ✔️ Healthera - A UK-based, B2B SaaS platform focused on digitizing the entire medication management process for pharmacies and consumers, serving over 1,600 pharmacies. 💊 Disease agnostic HQ: United Kingdom 📌 Seeking partnership opportunities, investors, or support from fellow digital health companies? Startups & digital health innovators can join the platform for #free. If you are curious to check the platform, please contact Linh Vo for a demo: https://bit.ly/4bNUhWT #globalhealth #innovationmanagement #healthopportunities #investors

The Future of Medicine is Targeted! Targeted drug delivery can change the healthcare system, with huge benefits for society and the economy, plus a wave of new market opportunities! ANGIE_h2020 #healthcare #targeteddrugdelivery #nanomedicine #society #economicinnovation #marketcreation #impact

📢VitruvianMD Secures US$10,000 As Winner Of Arab Health's Innov8 Competition "24 of the world's leading healthcare start-ups showcased the latest technologies in Artificial intelligence, drug delivery, BioTech, surgery, and medical devices, with VitruvianMD crowned the winner. VitruvianMD has won this year's Arab Health Innov8 competition and, with it, a cash prize of US$10,000, following an intensive week-long judging process that saw a total of 24 different companies pitch over the opening three days of Arab Health. VitruvianMD combines biomedical engineering and state-of-the-art artificial intelligence (AI) to deliver affordable, high-accuracy diagnostic tools for medical laboratories. This technology paves the way for laboratories to transition effortlessly into a digital pathology framework. In a world where diagnostician shortages remain an acute global challenge, particularly in regions like Sub- Saharan Africa with a concerning pathologist-to-population ratio, VitruvianMD's solutions stand to set new standards." Source https://lnkd.in/dazY9T5r

How exciting is the digital world? What role does digital therapeutics play in improving patient outcomes? How promising is this industry? What does the future look like? My comprehensive interview with TechSci Research tries to cover each of these questions and many more! P.S. It’s a long read, but would love to know your thoughts and questions in the comments.